stavudine has been researched along with Acquired Immune Deficiency Syndrome in 130 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (2.31) | 18.7374 |
1990's | 59 (45.38) | 18.2507 |
2000's | 45 (34.62) | 29.6817 |
2010's | 23 (17.69) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Broder, S; Driscoll, JS; Kim, CH; Marquez, VE; Mitsuya, H | 1 |
Ankrah, DNA; Lartey, M; Leufkens, HGM; Mantel-Teeuwisse, AK | 1 |
Borok, MZ; Campbell, TB; Makadzange, AT; Mhlanga, TO; Nelson, BC | 1 |
Ferradini, L; Madec, Y; Nerrienet, E; Ngo-Giang-Huong, N; Nouhin, J | 1 |
Dandara, C; Kampira, E; Kumwenda, J; Van Oosterhout, JJ | 1 |
Clifford, DB; Haas, DW; Johnson, DH; Leger, PD; Li, J; McLaren, PJ; Robbins, GK; Shafer, RW | 1 |
Aghokeng, AF; Chia, JE; Delaporte, E; Einterz, E; Eymard-Duvernay, S; Molina, JM; Mpoudi-Ngole, E; Peeters, M; Taieb, F | 1 |
Holla, P; Jameel, S; Munshi, SU; Panda, H; Rewari, BB | 1 |
Bedu-Addo, G; Chadwick, D; Norman, B; Phillips, R; Sarfo, FS; Sarfo, MA | 1 |
Fan, P; Li, J; Li, N; Liang, Y; Ma, Y; Sun, D; Wang, Z; Yang, W; Zhu, Q | 1 |
Sgarbi, JA | 1 |
Andrade, MC; Azevedo, MC; Eyer Silva, WA; Ferry, FR; Motta, RN; Nunes, RF; Pinto, JF; Silva, GA; Sugui, Dde A | 1 |
Fan, P; Li, N; Liang, Y; Nie, Y; Sun, D; Wang, Z; Yang, W; Zhu, Q | 1 |
Guedj, R | 1 |
Clifford, DB; Katabira, E; Musisi, S; Nakasujja, N; Robertson, K; Ronald, A; Sacktor, N; Skolasky, RL | 1 |
Iseniyi, JO; Odeigah, L; Olatunji, PO; Olawumi, HO; Salami, AK | 1 |
Castelnuovo, B; Kamya, M; Nanyonjo, A; Ocama, P | 1 |
Ag Aboubacrine, S; Coulibaly, S; Coulibaly, SM; Harama, M; Koumare, BY; Mariko, E; Oumar, AA; Traoré, HA | 1 |
Fujimoto, H; Fukutake, K; Funato, K; Hashimoto, Y; Yotsumoto, M | 1 |
Gurjar, M; Jivani, NP; Patel, MM; Singh, S; Sureja, S; Vaghani, SS | 1 |
Dhlomo, S; Emery, S; Grandits, G; Khabo, P; Khanyile, T; Komati, S; Magongoa, D; Naidoo, LC; Neaton, JD; Polis, M; Qolohle, D; Ratsela, A | 1 |
Ekwunife, OI; Iwuamadi, UI; Udeogaranya, OP; Ukwe, CV | 1 |
Domingo, P; Gutierrez, Mdel M; Mateo, MG; Vidal, F | 1 |
Azzoni, L; Ertl, HC; Firnhaber, C; Foulkes, AS; Gross, R; Li, Y; Montaner, LJ; Sanne, I; Stevens, W; Xiang, ZQ; Yin, X | 1 |
Bualert, L; Charungkiattikul, W; El Baidouri, F; Khositnithikul, R; Leelayoova, S; Mungthin, M; Naaglor, T; Ravel, C; Siripattanapipong, S; Thongsuksai, P | 1 |
Dragovic, G; Jevtovic, D | 1 |
Carda-Broch, S; Casas-Breva, I; Esteve-Romero, J; Peris-Vicente, J; Rambla-Alegre, M | 1 |
Gupta, U; Kumar, S; Nagpal, M; Tayal, V | 1 |
Han, Y; Li, TS; Li, YL; Qiu, ZF; Song, XJ; Su, YB; Xie, J; Yu, W | 1 |
Fox, L; Friedland, GH; Havlir, D; Pollard, RB; Richman, D; Smeaton, L; Tebas, P; Tierney, C | 1 |
Blanche, S; Bodemer, C; Brousse, N; Fardet, L; Fraitag, S | 1 |
Arnedo, M; Capon, A; Cruceta, A; Gallart, T; Garcia, F; Gatell, JM; Mestre, G; Miro, JM; Plana, M; Pumarola, T; Vidal, C | 1 |
Brew, BJ; Law, M; Tisch, S | 1 |
Desai, N; Mathur, M; Weedon, J | 1 |
Katano, H; Kimura, S; Niino, H; Oka, S; Teruya, K; Yamamoto, Y; Yasuoka, A | 1 |
Becker, SL; Danehower, SC; Fusco, GP; Fusco, JS; Graham, NM; Hansen, NI; Justice, AC; Sherrill, BH; Stein, DS | 1 |
Dressier, RM; James, CW; Steinhaus, MC; Szabo, S | 1 |
Chang, KH; Cho, BC; Choi, JY; Choi, SH; Han, SH; Kim, JM; Song, YG | 1 |
Bonmarchand, G; Boyer, A; Chadda, K; Salah, A | 1 |
Fleck, F | 1 |
Demeter, LM; Erice, A; Eshleman, SH; Fischl, MA; Hammer, SM; Hellmann, NS; Ribaudo, HJ | 1 |
Helen, L; Kanoksri, S; Siwaporn, C; Subsai, K | 1 |
Balestre, E; Bernardin, E; Bonnet, F; Dabis, F; Neau, D; Pellegrin, JL | 1 |
Ding, PP; Zhang, CY; Zheng, YH; Zhou, HY; Zou, W | 1 |
Murphy, RL; Parker, RA; Redfield, RR; Reisler, RB | 1 |
Lewis, W | 1 |
Cao, YZ; Han, Y; Li, TS; Qiu, ZF; Wang, AX; Xie, J | 1 |
Mahomed, FA; Rutherford, GW; Siegfried, NL; Van Deventer, PJ | 1 |
Bien, D; Boyd, MA; Carr, A; Cooper, DA; Krisanachinda, A; Lange, JM; Law, M; Lerdlum, S; Phanuphak, P; Reiss, P; Ruxrungtham, K; Srasuebkul, P; Wangsuphachart, S | 1 |
Chronister, CL | 1 |
Asiimwe, F; Behumbiize, P; Brooks, JT; Forna, F; Liechty, CA; Mermin, J; Solberg, P; Tong, T; Weidle, PJ; Were, W | 1 |
Chen, J; Ding, PP; He, Y; Li, H; Zhang, CY; Zheng, YH; Zhou, HY | 1 |
Chen, J; He, Y; Huang, ZL; Li, H; Liu, C; Liu, M; Ou, QY; Shen, Z; Zheng, YH | 1 |
Mitsuya, H | 1 |
Skowron, G | 1 |
Anderson, RE; Cross, A; Dunkle, LM; Hassett, J; Murray, HW; Sacks, HS; Sledz, S; Squires, KE; Weiss, W | 1 |
Burger, RA; Morrey, JD; Okleberry, K; Sidwell, RW; Warren, RP | 1 |
Rowe, PM | 1 |
Bechtold, CM; Federici, ME; Khan, NC; Li, H; Lin, PF; Patick, AK; Revie, DR; Rose, RE; Samanta, H; Trimble, J | 1 |
Browne, MJ; Chafee, SB; Denman, SL; Dudley, MN; Geletko, SM; Graham, KK; Mayer, KH; Posner, MR; Steinberg, SM; Zinner, SH | 1 |
Katz, MH | 1 |
Anderson, R; Dudley, MN; Dunkle, L; Horton, CM; Kaul, S; Mayer, KH; Squires, K | 1 |
Briqnac, H; Miller, LK; Olson, PE; Wallace, MR | 1 |
De Simone, C; Famularo, G; Longo, A; Marcellini, S; Moretti, S; Santini, G; Trinchieri, V; Tzantzoglou, S | 1 |
Hirschel, B; Rutschmann, O | 1 |
Heins, JR | 1 |
Craib, K; Gataric, N; Hogg, RS; Montaner, JS; O'Shaughnessy, MV; Schechter, MT; Yip, B | 1 |
Collins, DO; Sakamoto, A | 1 |
Balfour, HH; Chodakewitz, JA; Currier, JS; Demeter, LM; Deyton, LR; Eron, JJ; Feinberg, JE; Fischl, MA; Grimes, JM; Hammer, SM; Hughes, MD; Squires, KE | 1 |
Cottalorda, J; Lefbvre, JC; Mariani, R; Monpoux, F; Sirvent, N | 1 |
Chelstrom, LM; Dibirdik, I; Irvin, JD; Langlie, MC; Myers, DE; Tuel-Ahlgren, L; Uckun, FM | 1 |
Harms, M; Krischer, J; Pechère, M; Roten, SV; Rutschmann, O; Saurat, JH | 1 |
Antinori, A; De Luca, A; Ortona, L | 1 |
Baldeweg, T; Catalan, J; Gazzard, BG | 1 |
Cammack, N; Dalgleish, AG; Sharland, M; Watkins, AM; Westby, M | 1 |
Molina, JM | 1 |
Gilquin, J; Jubault, V; Kazatchkine, MD; Sert, C; Viard, JP | 1 |
Bontempo, FA; Dodson, SF; Fung, JJ; Hunt, SC; Ragni, MV | 1 |
Smith, L | 1 |
Arendt, G; Hefter, H; Jablonowski, H; von Giesen, HJ | 1 |
Hirschel, B; Marchal, F; Opravil, M; Perrin, L; Rutschmann, OT; Yerly, S | 1 |
Kisin, AV; Krugliak, IuL; Kurochkin, VK; Malekin, SI; Nosova, VM; Riakhovskiĭ, VV | 1 |
Galle, PR; Schramm, C; Wanitschke, R | 1 |
Elmadfa, I; Jilma, B; Parschalk, B; Pernerstorfer-Schoen, H; Schindl, A; Schindler, K; Thoeny-Lampert, S; Tschachler, E; Wunderer, K | 1 |
Fujimatsu, Y; Fukahori, S; Honda, J; Jojima, H; Oizumi, K; Okubo, Y; Shiraishi, K; Tanaka, K; Tanaka, M | 1 |
Ashraf, AB; Calvez, V; Colonno, RJ; Ferchal, F; Friedland, G; González, CJ; Griffith, B; Lin, PF; Mellors, JW; Schinazi, RF; Shepp, DH; Soriano, V; Wainberg, MA | 1 |
Belmonte, A; Montaner, JS; Salomon, H; Wainberg, MA | 1 |
Hart, AA; Hoetelmans, RM; Lange, JM; Mulder, JW; Reijers, MH; Reiss, P; Schuitemaker, H; Ten Kate, RW; Weigel, HM; Weverling, GJ | 1 |
Cherry, M | 1 |
Acosta, EP; Bassett, RL; Bell, D; Eron, JJ; Fife, K; Johnson, VA; Kuritzkes, DR; Marschner, IC; Martinez, A; Murphy, RL; Pettinelli, CB; Sommadossi, JP; Wood, K | 1 |
Albuzza, M; Amorico, G; Bedini, A; Esposito, R; Guaraldi, G; Orlando, G; Ventura, P | 1 |
Bartley, PB; Boots, RJ; Hyland, VJ; Lawson, M; Potter, JM; Westacott, L; Woods, ML | 1 |
Lasso, M; Noriega, LM; Northland, R; Pérez, J | 1 |
James, JS | 2 |
Mascolini, M | 1 |
Smart, T | 1 |
Zuger, A | 1 |
Baker, R | 1 |
Reiter, GS | 1 |
Golk, M | 1 |
Delaney, KM; Holmberg, SD; Lichtenstein, KA; Moorman, AC; Palella, FJ; Rhodes, PH; Ward, DJ; Wood, KC; Young, B | 1 |
Agut, H; Bonmarchand, M; Brun-Vezinet, F; Calvez, V; Costagliola, D; Coutellier, A; Delaugerre, C; Descamps, D; Izopet, J; Katlama, C; Massip, P; Matheron, S; Mouroux, M; Valantin, MA; Yvon, A | 1 |
Blanquet, D; Hage, F; Hallard, M; Mathe, G; Morette, C; Pontiggia, P | 1 |
Fakoya, A; Sarner, L | 1 |
Arnold, E; Das, K; DiCola, B; Fitzgibbon, JE; Gaur, S; John, JF; Nahass, R; Pottage, JC; Sha, BE | 1 |
Johnson, GM; Krogstad, PA; Lee, S; Mohan, K; Morse, EV; Nachman, S; Stanley, K; Van Dyke, RB; Wiznia, A | 1 |
Back, N; Bijen, M; Boucher, CA; de Graaf, L; Keulen, W; Kline, MW; Maxeiner, HG; Nijhuis, M; Schuurman, R; van Wijk, A | 1 |
Browne, M; Dudley, MN; Dunkle, L; Geletko, S; Graham, KK; Kaul, S; Mayer, K | 1 |
Broder, S; Kageyama, S; Mitsuya, H; Yarchoan, R | 1 |
Dunkle, LM; Fridland, A; Ghazzouli, I; Hitchcock, MJ; Kaul, S; Mansuri, MM; Martin, JC; Sterzycki, RZ | 1 |
Fukushima, S; Kawaguchi, T; Mishima, M; Nakano, M; Ohmura, M | 1 |
Dandekar, KA; Kaul, S; Pittman, KA | 1 |
11 review(s) available for stavudine and Acquired Immune Deficiency Syndrome
Article | Year |
---|---|
[AIDS: ethics and scientific investigation on human beings].
Topics: Acquired Immunodeficiency Syndrome; Adenine; Animals; Anti-HIV Agents; Azathioprine; Clinical Trials as Topic; Congresses as Topic; Cyclosporine; Developing Countries; Ditiocarb; Double-Blind Method; Drug Evaluation, Preclinical; Drug Therapy, Combination; Ethics Committees, Research; Human Experimentation; Humans; Informed Consent; Mass Media; Oligodeoxyribonucleotides, Antisense; Organophosphonates; Practice Guidelines as Topic; Stavudine; Tenofovir; Thionucleotides | 2008 |
Cutaneous EBV-related lymphoproliferative disorder in a 15-year-old boy with AIDS: an unusual clinical presentation.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Anti-HIV Agents; Antigens, CD; Antiretroviral Therapy, Highly Active; Combined Modality Therapy; Diagnosis, Differential; Epstein-Barr Virus Infections; Gene Rearrangement, T-Lymphocyte; Herpesvirus 4, Human; HIV Protease Inhibitors; Humans; Immunophenotyping; Indinavir; Lamivudine; Lymphoma, AIDS-Related; Lymphoma, T-Cell, Cutaneous; Male; Reverse Transcriptase Inhibitors; RNA, Viral; Sarcoma, Kaposi; Skin Neoplasms; Stavudine; Transfusion Reaction; Viral Matrix Proteins | 2002 |
Tenofovir-related nephrotoxicity: case report and review of the literature.
Topics: Acquired Immunodeficiency Syndrome; Acute Kidney Injury; Adenine; Anti-HIV Agents; Clinical Chemistry Tests; Fanconi Syndrome; Female; Humans; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Reverse Transcriptase Inhibitors; Stavudine; Tenofovir; Time Factors; Treatment Outcome | 2004 |
Thrombotic microangiopathy: an atypical cause of acute renal failure in patients with acute pancreatitis.
Topics: Acquired Immunodeficiency Syndrome; Acute Disease; Acute Kidney Injury; Adult; Hemolytic-Uremic Syndrome; Humans; Male; Pancreatitis; Pancreatitis, Alcoholic; Plasma Exchange; Purpura, Thrombotic Thrombocytopenic; Reverse Transcriptase Inhibitors; Stavudine | 2004 |
Nucleoside reverse transcriptase inhibitors, mitochondrial DNA and AIDS therapy.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Didanosine; DNA Replication; DNA, Mitochondrial; Humans; Lamivudine; Mitochondria; Nucleosides; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine | 2005 |
Stavudine, lamivudine and nevirapine combination therapy for treatment of HIV infection and AIDS in adults.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Nevirapine; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Stavudine | 2006 |
Biologic effects and safety of stavudine: overview of phase I and II clinical trials.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; Body Weight; CD4 Lymphocyte Count; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Dose-Response Relationship, Drug; HIV Core Protein p24; HIV Infections; Humans; Peripheral Nervous System Diseases; Stavudine | 1995 |
Effect of HIV treatment on cognition, behavior, and emotion.
Topics: Acquired Immunodeficiency Syndrome; Cognition Disorders; Cycloserine; Didanosine; Humans; Mental Disorders; Mood Disorders; Stavudine; Zidovudine | 1994 |
Antiretroviral therapy: a guide to the most important trials.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Clinical Trials as Topic; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Indinavir; Lamivudine; Nevirapine; Pyridines; Ritonavir; Saquinavir; Stavudine; Viral Load; Zalcitabine; Zidovudine | 1997 |
Targeted therapy of human immunodeficiency virus-related disease.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Antiviral Agents; CD4 Antigens; Didanosine; Dideoxynucleosides; Dipyridamole; Drug Synergism; Gene Expression Regulation, Viral; Genes, nef; Genes, rev; Genes, tat; HIV; HIV Protease; Interferon Type I; Organophosphonates; RNA-Directed DNA Polymerase; Stavudine; Transcription, Genetic; Zalcitabine; Zidovudine | 1991 |
Comparative studies of 2',3'-didehydro-2',3'-dideoxythymidine (D4T) with other pyrimidine nucleoside analogues.
Topics: Acquired Immunodeficiency Syndrome; Animals; Antiviral Agents; Dideoxynucleosides; HIV; Humans; Stavudine | 1990 |
27 trial(s) available for stavudine and Acquired Immune Deficiency Syndrome
Article | Year |
---|---|
Increased risk of Q151M and K65R mutations in patients failing stavudine-containing first-line antiretroviral therapy in Cambodia.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Amino Acid Substitution; Anti-HIV Agents; Base Sequence; Cambodia; Child; Child, Preschool; Drug Resistance, Multiple, Viral; Female; Follow-Up Studies; HIV Reverse Transcriptase; HIV-1; Humans; Male; Molecular Sequence Data; Mutation, Missense; Retrospective Studies; Stavudine; Zidovudine | 2013 |
Benefits and risks of stavudine therapy for HIV-associated neurologic complications in Uganda.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS Dementia Complex; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cognition Disorders; Developing Countries; Disability Evaluation; Female; Humans; Male; Neuropsychological Tests; Outcome Assessment, Health Care; Risk Assessment; Stavudine; Treatment Outcome; Uganda | 2009 |
Effect of highly active antiretroviral therapy on CD4 count and weight in AIDS patients seen at the UITH, Ilorin.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Aged; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Body Weight; CD4 Lymphocyte Count; Female; Hospitals, Teaching; Hospitals, University; Humans; Lamivudine; Male; Middle Aged; Nevirapine; Nigeria; Stavudine; Treatment Outcome | 2008 |
[The clinical and biological tolerance of nevirapine among patients with AIDS under treatment at the Hospital of the Point G].
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Drug Therapy, Combination; Female; Humans; Lamivudine; Male; Middle Aged; Nevirapine; Stavudine; Treatment Outcome | 2007 |
A randomized factorial trial comparing 4 treatment regimens in treatment-naive HIV-infected persons with AIDS and/or a CD4 cell count <200 cells/μL in South Africa.
Topics: Acquired Immunodeficiency Syndrome; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Didanosine; Drug Therapy, Combination; Female; HIV; Humans; Lamivudine; Lopinavir; Male; Pyrimidinones; Ritonavir; RNA, Viral; South Africa; Stavudine; Treatment Outcome; Zidovudine | 2010 |
Antiretroviral therapy interruptions result in loss of protective humoral immunity to neoantigens in HIV-infected individuals.
Topics: Acquired Immunodeficiency Syndrome; Adult; Africa South of the Sahara; Anti-HIV Agents; Antibodies, Neutralizing; Antigens, Viral; Autoantigens; CD4-Positive T-Lymphocytes; Drug Administration Schedule; Female; HIV-1; Humans; Immunity, Humoral; Lopinavir; Lymphocyte Activation; Male; Ritonavir; Stavudine; Viral Load | 2012 |
A phase II randomized study of the virologic and immunologic effect of zidovudine + stavudine versus stavudine alone and zidovudine + lamivudine in patients with >300 CD4 cells who were antiretroviral naive (ACTG 298).
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lamivudine; Male; Middle Aged; RNA, Viral; Stavudine; Zidovudine | 2002 |
Genotypic and phenotypic resistance patterns in early-stage HIV-1-infected patients failing initial therapy with stavudine, didanosine and nevirapine.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Didanosine; Drug Resistance, Viral; Drug Therapy, Combination; Genotype; HIV-1; Humans; Mutation; Nevirapine; Phenotype; Stavudine; Treatment Failure | 2002 |
HIV-1 drug resistance in subjects with advanced HIV-1 infection in whom antiretroviral combination therapy is failing: a substudy of AIDS Clinical Trials Group Protocol 388.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiretroviral Therapy, Highly Active; Drug Resistance, Viral; Female; Genotype; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Indinavir; Lamivudine; Male; Nelfinavir; Phenotype; Stavudine; Treatment Failure; Zidovudine | 2004 |
A one-year clinical trial using didanosine, stavudine and nevirapine for highly active antiretroviral therapy.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Child; Didanosine; Female; HIV-1; Humans; Immunophenotyping; Male; Middle Aged; Nevirapine; RNA, Viral; Stavudine; T-Lymphocytes | 2005 |
Incidence of pancreatitis in HIV-1-infected individuals enrolled in 20 adult AIDS clinical trials group studies: lessons learned.
Topics: Acquired Immunodeficiency Syndrome; Didanosine; Drug Therapy, Combination; HIV-1; Humans; Hydroxyurea; Incidence; Indinavir; National Institutes of Health (U.S.); Pancreatitis; Reverse Transcriptase Inhibitors; Stavudine; United States | 2005 |
T-cell response of advanced aids patients after highly active antiretroviral therapy.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; CD4-CD8 Ratio; CD8-Positive T-Lymphocytes; Didanosine; Female; Follow-Up Studies; Humans; Lymphocyte Count; Male; Middle Aged; Nevirapine; Stavudine; Viral Load | 2005 |
[Evaluation for two-year highly active antiretroviral therapy in Chinese HIV-1 infection patients].
Topics: Acquired Immunodeficiency Syndrome; Adult; Amylases; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Female; gamma-Glutamyltransferase; Gastrointestinal Diseases; HIV Infections; HIV-1; Humans; Inosine; Male; Middle Aged; Neuritis; Nevirapine; RNA, Viral; Stavudine; Time Factors; Treatment Outcome; Viral Load | 2007 |
Biologic effects and safety of stavudine: overview of phase I and II clinical trials.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; Body Weight; CD4 Lymphocyte Count; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Dose-Response Relationship, Drug; HIV Core Protein p24; HIV Infections; Humans; Peripheral Nervous System Diseases; Stavudine | 1995 |
Stavudine in patients with AIDS and AIDS-related complex: AIDS clinical trials group 089.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Complex; Body Weight; CD4 Lymphocyte Count; Female; HIV Core Protein p24; Humans; Male; Middle Aged; Peripheral Nervous System Diseases; Proportional Hazards Models; Stavudine; Survival Analysis | 1995 |
2',3'-didehydro-3'-deoxythymidine (d4T) in patients with AIDS or AIDS-related complex: a phase I trial.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Complex; Antiviral Agents; CD4-Positive T-Lymphocytes; Dideoxynucleosides; Female; HIV Core Protein p24; Humans; Leukocyte Count; Male; Middle Aged; Peripheral Nervous System Diseases; Stavudine | 1993 |
Population pharmacokinetics of stavudine (d4T) in patients with AIDS or advanced AIDS-related complex.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Aged, 80 and over; AIDS-Related Complex; Antiviral Agents; Female; Humans; Male; Middle Aged; Models, Biological; Stavudine | 1995 |
Acetyl-carnitine deficiency in AIDS patients with neurotoxicity on treatment with antiretroviral nucleoside analogues.
Topics: Acetylcarnitine; Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Axons; Cross-Sectional Studies; Didanosine; Female; Humans; Male; Middle Aged; Peripheral Nervous System Diseases; Reverse Transcriptase Inhibitors; Stavudine; Zalcitabine | 1997 |
A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Male; Reverse Transcriptase Inhibitors; RNA, Viral; Stavudine; Zidovudine | 1997 |
Stavudine, lamivudine and indinavir in children with advanced HIV-1 infection: preliminary experience.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Child; Child, Preschool; Drug Therapy, Combination; Female; HIV Protease Inhibitors; Humans; Indinavir; Infectious Disease Transmission, Vertical; Lamivudine; Male; Pilot Projects; Retrospective Studies; Stavudine; Zidovudine | 1997 |
Cell-associated HIV-1 RNA in blood as indicator of virus load in lymph nodes. The Swiss HIV Cohort Study.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; CD4-CD8 Ratio; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Didanosine; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Hydroxyurea; Lymph Nodes; RNA, Viral; Stavudine; Viral Load | 1999 |
Toxicity and drug exposure in a quadruple drug regimen in HIV-1 infected patients participating in the ADAM study.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Diarrhea; Drug Therapy, Combination; Female; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Liver; Male; Middle Aged; Nausea; Nelfinavir; Reverse Transcriptase Inhibitors; Saquinavir; Stavudine | 2000 |
Continued lamivudine versus delavirdine in combination with indinavir and zidovudine or stavudine in lamivudine-experienced patients: results of Adult AIDS Clinical Trials Group protocol 370.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Delavirdine; Female; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Male; Reverse Transcriptase Inhibitors; Stavudine; Time Factors; Viral Load; Zidovudine | 2000 |
Combination therapy dramatically reduces viral load.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Double-Blind Method; Drug Therapy, Combination; Humans; Stavudine; Viral Load | 1996 |
D4T: new clinical data confirms benefit.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Drug Approval; Humans; Stavudine; Treatment Outcome | 1995 |
Reported adherence as a determinant of response to highly active antiretroviral therapy in children who have human immunodeficiency virus infection.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Child; Child, Preschool; Drug Administration Schedule; Humans; Lamivudine; Nelfinavir; Nevirapine; Patient Compliance; Ritonavir; RNA, Viral; Stavudine; Treatment Outcome; Viral Load | 2002 |
Pharmacokinetics of stavudine in patients with AIDS or AIDS-related complex.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Complex; Antiviral Agents; Demography; Dideoxynucleosides; Dose-Response Relationship, Drug; Drug Evaluation; Female; Humans; Male; Middle Aged; Stavudine | 1992 |
93 other study(ies) available for stavudine and Acquired Immune Deficiency Syndrome
Article | Year |
---|---|
Potential anti-AIDS drugs. 2',3'-Dideoxycytidine analogues.
Topics: Acquired Immunodeficiency Syndrome; Cell Line; Chemical Phenomena; Chemistry; Deoxycytidine; HIV; Structure-Activity Relationship; T-Lymphocytes, Helper-Inducer; Zalcitabine | 1987 |
Five-year trends in treatment changes in an adult cohort of HIV/AIDS patients in Ghana: a retrospective cohort study.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cohort Studies; Female; Ghana; HIV Infections; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Retrospective Studies; Stavudine; Tenofovir; Young Adult; Zidovudine | 2017 |
AIDS-associated Kaposi sarcoma: outcomes after initiation of antiretroviral therapy at a university-affiliated hospital in urban Zimbabwe.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Coinfection; Drug Therapy, Combination; Female; Herpesvirus 8, Human; HIV-1; Hospitals, University; Humans; Kaplan-Meier Estimate; Lamivudine; Male; Multivariate Analysis; Nevirapine; Proportional Hazards Models; Retrospective Studies; Sarcoma, Kaposi; Stavudine; Treatment Outcome; Urban Population; Zimbabwe | 2013 |
Mitochondrial subhaplogroups and differential risk of stavudine-induced lipodystrophy in Malawian HIV/AIDS patients.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiretroviral Therapy, Highly Active; DNA, Mitochondrial; Female; Genetic Predisposition to Disease; Haplotypes; HIV; HIV Infections; Humans; Lipodystrophy; Male; Middle Aged; Mitochondria; Stavudine | 2013 |
Genome-wide association study of peripheral neuropathy with D-drug-containing regimens in AIDS Clinical Trials Group protocol 384.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Case-Control Studies; Drug Combinations; Drug Therapy, Combination; Genome-Wide Association Study; Genotype; Humans; Lamivudine; Multicenter Studies as Topic; Peripheral Nervous System Diseases; Polymorphism, Genetic; Principal Component Analysis; Randomized Controlled Trials as Topic; Retrospective Studies; Stavudine; Treatment Outcome; Zidovudine | 2014 |
Challenges of antiretroviral treatment monitoring in rural and remote-access regions in Africa.
Topics: Acquired Immunodeficiency Syndrome; Adult; Africa; Alkynes; Anti-HIV Agents; Benzoxazines; Cross-Sectional Studies; Cyclopropanes; Drug Monitoring; Drug Resistance, Viral; Female; HIV-1; Hospitals, Rural; Humans; Lamivudine; Male; Middle Aged; Nevirapine; Rural Health Services; Rural Population; Stavudine; Treatment Outcome; Zidovudine | 2014 |
MicroRNA-150 is a potential biomarker of HIV/AIDS disease progression and therapy.
Topics: Acquired Immunodeficiency Syndrome; Adult; Alkynes; Antiretroviral Therapy, Highly Active; Benzoxazines; Biomarkers; CD4 Lymphocyte Count; Cyclopropanes; Disease Progression; Drug Resistance, Viral; Female; Gene Expression Regulation; HIV; Humans; Lamivudine; Leukocytes, Mononuclear; Male; MicroRNAs; Nevirapine; Stavudine; Treatment Outcome; Viral Load; Zidovudine | 2014 |
Risk of deaths, AIDS-defining and non-AIDS defining events among Ghanaians on long-term combination antiretroviral therapy.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Aged; Anti-Retroviral Agents; Cohort Studies; Diarrhea; Female; Ghana; HIV Infections; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Proportional Hazards Models; Risk Factors; Stavudine; Treatment Outcome; Tuberculosis, Pulmonary; Young Adult | 2014 |
[Analysis on HIV suppression effect after initiating antiretroviral treatment and related factors among AIDS patients in Henan province during 2008 and 2013].
Topics: Acquired Immunodeficiency Syndrome; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Female; Health Facilities; HIV Infections; Humans; Lamivudine; Male; Nevirapine; Stavudine; Time-to-Treatment; Treatment Outcome; Zidovudine | 2015 |
Autoimmune thyroid disease: what secrets we still need to unravel?
Topics: Acquired Immunodeficiency Syndrome; Autoantibodies; Diabetes Mellitus, Type 1; Female; Humans; Hypothyroidism; Iodide Peroxidase; Male; Reverse Transcriptase Inhibitors; Stavudine; Thyroid Diseases | 2015 |
Association between antiretrovirals and thyroid diseases: a cross-sectional study.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-Retroviral Agents; Asymptomatic Diseases; Autoantibodies; CD4 Lymphocyte Count; Cross-Sectional Studies; Didanosine; Female; Humans; Hypothyroidism; Iodide Peroxidase; Male; Prevalence; Reverse Transcriptase Inhibitors; Stavudine; Thyroid Diseases | 2015 |
[Survival analysis of AIDS patients of 15 years or above years old after initiation antiretroviral treatment in Henan province during 2005 to 2014].
Topics: Acquired Immunodeficiency Syndrome; Anti-Retroviral Agents; China; Drug Therapy, Combination; Female; Humans; Lymphocyte Count; Male; Nevirapine; Proportional Hazards Models; Retrospective Studies; Risk Factors; Stavudine; Survival Analysis; Survival Rate; Zidovudine | 2015 |
Is it safe to switch from stavudine to zidovudine after developing symptomatic hyperlactatemia?
Topics: Acidosis, Lactic; Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Female; Humans; Middle Aged; Stavudine; Treatment Outcome; Uganda; Zidovudine | 2008 |
Central nervous system T-cell lymphoma in acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Agents; Antiretroviral Therapy, Highly Active; Brain; Central Nervous System Neoplasms; Humans; Lamivudine; Lymphoma, T-Cell; Magnetic Resonance Imaging; Male; Methotrexate; Pyrrolidinones; Raltegravir Potassium; Stavudine; Treatment Outcome | 2010 |
Design, characterization and in vitro evaluation of stavudine-loaded microspheres.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Calorimetry, Differential Scanning; Delayed-Action Preparations; Humans; Microscopy, Electron, Scanning; Microspheres; Particle Size; Polymethacrylic Acids; Spectroscopy, Fourier Transform Infrared; Stavudine | 2011 |
Self-reported adherence to HAART in South-Eastern Nigeria is related to patients' use of pill box.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Aged; Algorithms; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Feasibility Studies; Female; HIV; HIV Infections; Humans; Lamivudine; Linear Models; Male; Medication Adherence; Middle Aged; Nevirapine; Nigeria; Patient Satisfaction; Prospective Studies; Reminder Systems; Risk Factors; Self Report; Stavudine; Surveys and Questionnaires; Treatment Outcome | 2010 |
Drug safety evaluation profile of stavudine plus lamivudine for HIV-1/AIDS infection.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Drug Therapy, Combination; Evidence-Based Medicine; HIV Infections; HIV-1; Humans; Lamivudine; Patient Safety; Reverse Transcriptase Inhibitors; Risk Assessment; Risk Factors; Stavudine; Treatment Outcome | 2012 |
Autochthonous disseminated dermal and visceral leishmaniasis in an AIDS patient, southern Thailand, caused by Leishmania siamensis.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Female; Genes, Protozoan; Humans; Lamivudine; Leishmania; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Nevirapine; Phylogeny; Stavudine; Thailand | 2012 |
The role of nucleoside reverse transcriptase inhibitors usage in the incidence of hyperlactatemia and lactic acidosis in HIV/AIDS patients.
Topics: Acidosis, Lactic; Acquired Immunodeficiency Syndrome; Adult; CD4 Lymphocyte Count; Didanosine; Drug Therapy, Combination; Female; Follow-Up Studies; HIV Infections; Humans; Incidence; Lactic Acid; Male; Middle Aged; Prospective Studies; Reverse Transcriptase Inhibitors; Risk Factors; Sex Factors; Stavudine | 2012 |
Monitoring of HAART regime antiretrovirals in serum of acquired immunodeficiency syndrome patients by micellar liquid chromatography.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Chromatography, Liquid; Cyclopropanes; Drug Monitoring; Humans; Lamivudine; Organophosphonates; Stavudine; Tenofovir; Zidovudine | 2012 |
Adverse drug reactions to antiretroviral therapy in AIDS patients at a tertiary care hospital in India: A prospective observational study.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Central Nervous System Diseases; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Humans; India; Lamivudine; Male; Medication Adherence; Middle Aged; Nevirapine; Severity of Illness Index; Stavudine; Tertiary Care Centers | 2010 |
[The influence of long-term nucleotide reverse transcriptase inhibitors on lipids metabolism in HIV/AIDS patients].
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiretroviral Therapy, Highly Active; Case-Control Studies; Cross-Sectional Studies; Female; HIV Infections; Humans; Lipid Metabolism; Lipodystrophy; Male; Middle Aged; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine | 2012 |
Lactate concentrations distinguish between nucleoside neuropathy and HIV neuropathy.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Humans; Lactates; Peripheral Nervous System Diseases; Sensitivity and Specificity; Stavudine; Viral Load | 2003 |
Lactate levels in children with HIV/AIDS on highly active antiretroviral therapy.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Biomarkers; Child; Child, Preschool; Female; HIV Protease Inhibitors; Humans; Infant; Lactic Acid; Male; Patient Compliance; Reverse Transcriptase Inhibitors; Ritonavir; Stavudine; Viral Load | 2003 |
Hope for South Africa--at last.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Drug Industry; Drugs, Generic; Financing, Government; Health Policy; HIV Infections; Humans; South Africa; Stavudine | 2003 |
Rapidly progressive human herpesvirus 8-associated solid anaplastic lymphoma in a patient with AIDS--associated Kaposi sarcoma.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Cyclophosphamide; Disease Progression; Doxorubicin; Epstein-Barr Virus Infections; Fatal Outcome; Gastrointestinal Neoplasms; Herpesviridae Infections; Herpesvirus 4, Human; Herpesvirus 8, Human; HIV-1; Humans; Lamivudine; Lymphoma, AIDS-Related; Lymphoma, Large B-Cell, Diffuse; Male; Neoplasms, Second Primary; Prednisone; Ritonavir; Saquinavir; Sarcoma, Kaposi; Skin Neoplasms; Stavudine; Tumor Virus Infections; Vincristine | 2003 |
[Long-term tolerance. Preventing lipoatrophy].
Topics: Acquired Immunodeficiency Syndrome; Antiretroviral Therapy, Highly Active; Clinical Trials as Topic; Dideoxynucleosides; DNA, Mitochondrial; Drug Combinations; HIV-Associated Lipodystrophy Syndrome; Humans; Lamivudine; Long-Term Care; Risk Factors; Stavudine; Zidovudine | 2003 |
Disease progression in HIV-infected patients treated with stavudine vs. zidovudine.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Databases, Factual; Disease Progression; Disease-Free Survival; Follow-Up Studies; HIV Infections; HIV Wasting Syndrome; Humans; Proportional Hazards Models; Prospective Studies; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine | 2004 |
A case of lactic acidosis caused by stavudine in an AIDS patient.
Topics: Acidosis, Lactic; Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Female; Humans; Sodium Bicarbonate; Stavudine | 2004 |
WHO hopes 3-by-5 plan will reverse Africa's HIV/AIDS epidemic.
Topics: Acquired Immunodeficiency Syndrome; Adult; Africa; Anti-HIV Agents; Child; Developing Countries; Disease Outbreaks; Drug Combinations; Female; Foster Home Care; HIV Infections; Humans; Lamivudine; Male; Nevirapine; Reverse Transcriptase Inhibitors; Stavudine; United Nations; World Health Organization | 2004 |
Tenofovir: new indication. For first-line antiretroviral therapy: wait and see.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Controlled Clinical Trials as Topic; Didanosine; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Lamivudine; Reverse Transcriptase Inhibitors; Stavudine; Treatment Outcome; Zidovudine | 2004 |
Neurological complications in AIDS patients: the 1-year retrospective study in Chiang Mai University, Thailand.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; AIDS Dementia Complex; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cytomegalovirus Infections; Female; Humans; Lamivudine; Male; Meningitis, Cryptococcal; Middle Aged; Retrospective Studies; Stavudine; Toxoplasmosis | 2004 |
Risk factors for hyperlactataemia in HIV-infected patients, Aquitaine Cohort, 1999--2003.
Topics: Acidosis, Lactic; Acquired Immunodeficiency Syndrome; Adult; Age Factors; Anti-HIV Agents; CD4 Antigens; Cohort Studies; Didanosine; Drug Therapy, Combination; HIV-Associated Lipodystrophy Syndrome; Humans; Lactic Acid; Longitudinal Studies; Male; Middle Aged; Reverse Transcriptase Inhibitors; Stavudine; Triglycerides | 2005 |
Changes in body composition and mitochondrial nucleic acid content in patients switched from failed nucleoside analogue therapy to ritonavir-boosted indinavir and efavirenz.
Topics: Absorptiometry, Photon; Acquired Immunodeficiency Syndrome; Adult; Body Composition; DNA, Mitochondrial; HIV Protease Inhibitors; Humans; Indinavir; Lumbar Vertebrae; Middle Aged; Mitochondria; Reverse Transcriptase Inhibitors; Ritonavir; RNA; RNA, Mitochondrial; RNA, Viral; Stavudine; Tomography, X-Ray Computed; Treatment Failure; Treatment Outcome; Viral Load; Zidovudine | 2006 |
Discontinuation of highly active antiretroviral therapy leads to cryptococcal meningitis/choroiditis in an AIDS patient.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Choroiditis; Cryptococcus neoformans; Dideoxynucleosides; Eye Infections, Fungal; Follow-Up Studies; Humans; Male; Meningitis, Cryptococcal; Middle Aged; Ritonavir; Saquinavir; Stavudine | 2006 |
Clinical toxicity of highly active antiretroviral therapy in a home-based AIDS care program in rural Uganda.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4 Lymphocyte Count; Chemical and Drug Induced Liver Injury; Cyclopropanes; Exanthema; Female; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Multivariate Analysis; Nevirapine; Pancreatitis; Peripheral Nervous System Diseases; Proportional Hazards Models; Rural Health; Stavudine; Survival Analysis; Uganda | 2007 |
Evaluation of human immunodeficiency virus type 1-infected Chinese patients treated with highly active antiretroviral therapy for two years.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Child; Didanosine; Female; HIV-1; Humans; Lymphocyte Activation; Male; Middle Aged; Nevirapine; Stavudine | 2007 |
[AIDS therapy with reverse transcriptase inhibitors].
Topics: Acquired Immunodeficiency Syndrome; Didanosine; Drug Therapy, Combination; Humans; Lamivudine; Reverse Transcriptase Inhibitors; Stavudine; Zalcitabine; Zidovudine | 1993 |
Drugs for AIDS and associated infections.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Antiprotozoal Agents; Antiviral Agents; Atovaquone; Candidiasis, Oral; Clindamycin; Clotrimazole; Cryptosporidiosis; Cytomegalovirus Infections; Dapsone; Didanosine; Drug Combinations; Drug Therapy, Combination; Fluconazole; Flucytosine; Folic Acid Antagonists; Foscarnet; Glucuronates; Herpes Simplex; Herpes Zoster; Humans; Isoniazid; Itraconazole; Ketoconazole; Lamivudine; Mycobacterium avium-intracellulare Infection; Naphthoquinones; Nystatin; Pentamidine; Pneumocystis Infections; Pneumonia, Pneumocystis; Prednisone; Primaquine; Reverse Transcriptase Inhibitors; Stavudine; Syphilis; Toxoplasmosis; Trimetrexate; Tuberculosis; Zalcitabine; Zidovudine | 1995 |
Effect of the combination of interferon-alpha and stavudine on Friend virus infections in (B10.A x A.By)F1 mice.
Topics: Acquired Immunodeficiency Syndrome; Animals; Cells, Cultured; Cytotoxicity, Immunologic; Drug Synergism; Drug Therapy, Combination; Female; Friend murine leukemia virus; Interferon-alpha; Leukemia, Experimental; Male; Mice; Mice, Inbred Strains; Retroviridae Infections; Stavudine; Tumor Virus Infections | 1995 |
Another HIV drug.
Topics: Acquired Immunodeficiency Syndrome; Drug Approval; Humans; Stavudine; United States; United States Food and Drug Administration | 1994 |
Stavudine (d4T) for HIV.
Topics: Acquired Immunodeficiency Syndrome; Drug Approval; Humans; Stavudine | 1994 |
Genotypic and phenotypic analysis of human immunodeficiency virus type 1 isolates from patients on prolonged stavudine therapy.
Topics: Acquired Immunodeficiency Syndrome; Base Sequence; Drug Resistance; Genotype; HIV-1; Humans; Molecular Sequence Data; Phenotype; Stavudine; Zidovudine | 1994 |
Committee recommends approval of AIDS drug.
Topics: Acquired Immunodeficiency Syndrome; Drug Approval; Humans; Stavudine; United States; United States Food and Drug Administration | 1994 |
Experimental AIDS drug, d4T, now available to patients in critical need.
Topics: Acquired Immunodeficiency Syndrome; Drug Approval; Drugs, Investigational; Humans; Stavudine | 1993 |
Stavudine made available under parallel track policy.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Dideoxynucleosides; Drug Approval; Health Policy; Humans; Stavudine; United States; United States Food and Drug Administration | 1993 |
Experimental AIDS drug, d4T, now available to patients in critical need.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Critical Care; Dideoxynucleosides; Drugs, Investigational; Humans; Stavudine | 1993 |
Experimental AIDS drug d4T, now available to patients in critical need.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Dideoxynucleosides; Drug Approval; Drugs, Investigational; Humans; Stavudine; United States; United States Food and Drug Administration | 1993 |
[AIDS studies with didanosine and stavudine].
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Clinical Trials as Topic; Didanosine; Drug Therapy, Combination; HIV-1; Humans; Stavudine | 1996 |
Clinical experience with stavudine as salvage therapy in patients with advanced HIV disease.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Antiviral Agents; Body Weight; HIV Infections; Humans; Middle Aged; Salvage Therapy; Stavudine | 1996 |
Treatment options for human immunodeficiency virus.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Child; Didanosine; Drug Approval; Female; HIV Infections; HIV Protease Inhibitors; Humans; Infant, Newborn; Lamivudine; Male; Saquinavir; Stavudine; United States; United States Food and Drug Administration; Zalcitabine; Zidovudine | 1996 |
Decline in deaths from AIDS due to new antiretrovirals.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; British Columbia; CD4 Lymphocyte Count; Drug Therapy, Combination; Humans; Indinavir; Lamivudine; Mortality; Saquinavir; Stavudine | 1997 |
Cure or control of HIV/AIDS?
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Didanosine; Drug Resistance, Microbial; Drug Therapy, Combination; HIV; HIV Infections; Humans; Indinavir; Lamivudine; Models, Biological; Nevirapine; Pyridines; Ritonavir; Saquinavir; Stavudine; Zalcitabine; Zidovudine | 1997 |
TXU (anti-CD7)-pokeweed antiviral protein as a potent inhibitor of human immunodeficiency virus.
Topics: Acquired Immunodeficiency Syndrome; Animals; Anti-HIV Agents; Disease Models, Animal; HIV-1; Humans; Immunoconjugates; Macaca fascicularis; Mice; Mice, SCID; N-Glycosyl Hydrolases; Plant Proteins; Ribosome Inactivating Proteins, Type 1; Stavudine; Zidovudine | 1998 |
Neutrophil eccrine hidradenitis in a patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Biopsy, Needle; Follow-Up Studies; Hidradenitis; Humans; Remission Induction; Reverse Transcriptase Inhibitors; Stavudine | 1998 |
Antiretroviral therapy and improving AIDS survival.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; HIV Protease Inhibitors; Humans; Lamivudine; Reverse Transcriptase Inhibitors; Stavudine; Survival Analysis | 1998 |
Risk of HIV dementia and opportunistic brain disease in AIDS and zidovudine therapy.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS Dementia Complex; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Brain Diseases; Didanosine; Female; Follow-Up Studies; Humans; Longitudinal Studies; Male; Retrospective Studies; Risk; Stavudine; Treatment Outcome; Zalcitabine; Zidovudine | 1998 |
Immune reconstitution in HAART-treated children with AIDS. Highly Active Anti-Retroviral Therapy.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; CD4 Lymphocyte Count; CD8-Positive T-Lymphocytes; Child; Disease Progression; Female; Follow-Up Studies; Humans; Immunity, Cellular; Immunologic Memory; Lamivudine; Lymphocyte Count; Nelfinavir; Stavudine; Viral Load | 1998 |
[The role of stavudine in antiretroviral therapy].
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; HIV Infections; Humans; Retroviridae; Retroviridae Infections; Reverse Transcriptase Inhibitors; Stavudine | 1998 |
Delayed occurrence of Graves' disease after immune restoration with HAART. Highly active antiretroviral therapy.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Autoimmune Diseases; CD4-Positive T-Lymphocytes; Female; Graves Disease; Humans; Immunity; Indinavir; Lamivudine; Male; Ritonavir; Stavudine | 1998 |
Liver transplantation in a hemophilia patient with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Hemophilia A; Hepatitis C; HIV Protease Inhibitors; Humans; Lamivudine; Liver Failure; Liver Transplantation; Male; Stavudine; Viral Load | 1999 |
AIDS: the new drug war.
Topics: Acquired Immunodeficiency Syndrome; Black or African American; Dideoxynucleosides; Drug Combinations; Drug Industry; Humans; Investments; Lamivudine; Stavudine; United States; Zidovudine | 1998 |
Stavudine and the peripheral nerve in HIV-1 infected patients.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Drug Therapy, Combination; Female; HIV-1; Humans; Male; Middle Aged; Peripheral Nerves; Stavudine | 1999 |
[Conjugates of 2',3'-didehydro-3'-deoxythymidine with thymogen. Synthesis and anti-HIV activity].
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Dipeptides; HIV-1; Humans; Peptides; Stavudine | 1999 |
Thiamine for the treatment of nucleoside analogue-induced severe lactic acidosis.
Topics: Acidosis, Lactic; Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Didanosine; Female; Humans; Parenteral Nutrition, Total; Stavudine; Thiamine | 1999 |
Beneficial effects of protease inhibitors on body composition and energy expenditure: a comparison between HIV-infected and AIDS patients.
Topics: Acquired Immunodeficiency Syndrome; Adult; Basal Metabolism; Body Composition; Body Weight; Case-Control Studies; Cohort Studies; Didanosine; Energy Metabolism; Female; HIV Infections; HIV Protease Inhibitors; Humans; Longitudinal Studies; Male; Middle Aged; Nelfinavir; Prospective Studies; Stavudine; Viremia | 1999 |
[Fatal lactic acidosis in a patient with acquired immunodeficiency syndrome treated with stavudine, lamivudine and indinavir].
Topics: Acidosis, Lactic; Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Drug Therapy, Combination; Fatal Outcome; Humans; Indinavir; Lamivudine; Male; Middle Aged; Reverse Transcriptase Inhibitors; Stavudine | 1999 |
Stavudine resistance: an update on susceptibility following prolonged therapy.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Drug Resistance; HIV-1; Humans; Phenotype; RNA-Directed DNA Polymerase; Stavudine | 1999 |
Diminished HIV-1 sensitivity to stavudine in patients on prolonged therapy occurs only at low levels and cannot be attributed to any single amino acid substitution in reverse transcriptase.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Drug Resistance; HIV Reverse Transcriptase; HIV-1; Humans; Point Mutation; Reverse Transcriptase Inhibitors; Stavudine; Time Factors | 1998 |
Deaths bring South African HIV drug trials to a premature halt.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Clinical Trials as Topic; Deoxycytidine; Drug Therapy, Combination; Emtricitabine; Female; Humans; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Pregnant Women; Research Subjects; Reverse Transcriptase Inhibitors; South Africa; Stavudine | 2000 |
Pathological fractures in AIDS patients with osteopenia and osteoporosis induced by antiretroviral therapy.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Bone Diseases, Metabolic; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Male; Middle Aged; Osteoporosis; Reverse Transcriptase Inhibitors; Rib Fractures; Spinal Fractures; Stavudine | 2001 |
Large hepatic mitochondrial DNA deletions associated with L-lactic acidosis and highly active antiretroviral therapy.
Topics: Acidosis, Lactic; Acquired Immunodeficiency Syndrome; Antiretroviral Therapy, Highly Active; DNA, Mitochondrial; Humans; Lamivudine; Male; Middle Aged; Saquinavir; Sequence Deletion; Stavudine | 2001 |
[Fatal lactic acidosis in a patient with acquired immunodeficiency syndrome treated with highly active antiretroviral therapy. Report of a case].
Topics: Acidosis, Lactic; Acquired Immunodeficiency Syndrome; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Didanosine; Fatal Outcome; Female; Humans; Oxazines; Severity of Illness Index; Stavudine | 2000 |
Twice daily dosing study of Viracept.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; CD4 Lymphocyte Count; Drug Administration Schedule; Drug Therapy, Combination; Humans; Lamivudine; Nelfinavir; Stavudine | 1998 |
Winnipeg conference. What do the numbers mean?
Topics: Acquired Immunodeficiency Syndrome; AIDS Serodiagnosis; AIDS Vaccines; AIDS-Related Opportunistic Infections; Antigens, Viral; Antiviral Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Cytomegalovirus; Drug Therapy, Combination; Female; Gonorrhea; HIV Infections; HIV-1; Humans; Interleukin-2; Male; Mycobacterium; Papanicolaou Test; Patient Care Team; Pneumonia, Pneumocystis; Polymerase Chain Reaction; Rectal Diseases; RNA, Viral; Species Specificity; Stavudine; Vaginal Smears; Weight Loss | 1995 |
d4T dose clarification.
Topics: Acquired Immunodeficiency Syndrome; Drug Administration Schedule; Drug Tolerance; Humans; Stavudine | 1995 |
FDA triple header. Food and Drug Administration.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; CD4 Lymphocyte Count; Child; Didanosine; Drug Resistance, Microbial; Drug Therapy, Combination; HIV Protease Inhibitors; Humans; Isoquinolines; Lamivudine; Mutation; Quinolines; Salvage Therapy; Saquinavir; Stavudine; United States; United States Food and Drug Administration; Zalcitabine; Zidovudine | 1995 |
FDA antiviral advisory hearings on lamivudine (Epivir, 3TC), saquinavir (Invirase), stavudine (Zerit, d4T), November 6-8. Food and Drug Administration.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; CD4 Lymphocyte Count; Drug Resistance, Microbial; HIV Protease Inhibitors; Humans; Isoquinolines; Lamivudine; Quinolines; Saquinavir; Stavudine; United States; United States Food and Drug Administration; Zalcitabine | 1995 |
Top AIDS researchers' strategy for antiretroviral treatment.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; CD4 Lymphocyte Count; Didanosine; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Patient Compliance; Practice Guidelines as Topic; RNA, Viral; Stavudine; Zalcitabine; Zidovudine | 1996 |
d4T+AZT--unexpected CD4 drop seen in study.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; CD4 Lymphocyte Count; Drug Therapy, Combination; Humans; Practice Patterns, Physicians'; Stavudine; Zidovudine | 1996 |
Treating a survivor.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Counseling; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Male; Mycobacterium avium-intracellulare Infection; Pneumonia, Pneumocystis; Reverse Transcriptase Inhibitors; Stavudine; Treatment Outcome; Zidovudine | 1997 |
3-drug therapy reduces deaths and new AIDS-related illnesses by 50%.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine | 1997 |
Hepatitis in an HIV-infected man.
Topics: Acquired Immunodeficiency Syndrome; Adult; Alcohol Drinking; Anti-HIV Agents; Drug Therapy, Combination; Humans; Lamivudine; Liver; Liver Function Tests; Male; Nevirapine; Stavudine | 1997 |
To AIDS and back with Norvir, D4T, 3TC and nutritional therapies. An interview with Michael Golk.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; CD4 Lymphocyte Count; Dietary Fats; Drug Therapy, Combination; HIV Protease Inhibitors; Humans; Hypercholesterolemia; Killer Cells, Natural; Lamivudine; Reverse Transcriptase Inhibitors; Ritonavir; Stavudine; Triglycerides | 1998 |
Clinical assessment of HIV-associated lipodystrophy in an ambulatory population.
Topics: Acquired Immunodeficiency Syndrome; Adult; Age Factors; Anti-HIV Agents; Body Mass Index; CD4 Lymphocyte Count; Cohort Studies; Data Interpretation, Statistical; Female; HIV Protease Inhibitors; Humans; Indinavir; Lipodystrophy; Male; Middle Aged; Prevalence; Reverse Transcriptase Inhibitors; Risk Factors; Stavudine; Viral Load | 2001 |
Low-rate emergence of thymidine analogue mutations and multi-drug resistance mutations in the HIV-1 reverse transcriptase gene in therapy-naive patients receiving stavudine plus lamivudine combination therapy.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Drug Resistance, Multiple, Viral; Drug Therapy, Combination; Genotype; HIV Reverse Transcriptase; Humans; Lamivudine; Mutation; Stavudine; Viral Load; Zidovudine | 2001 |
Viral and immunologic follow up of 4 to 9 years of AIDS treatments by quadruple combinations of virostatics including integrase inhibitors applied in short sequences differing by drug rotation.
Topics: Acquired Immunodeficiency Syndrome; Acriflavine; Adult; Anti-HIV Agents; Antiviral Agents; CD4-CD8 Ratio; Didanosine; Drug Therapy, Combination; Ellipticines; Female; Follow-Up Studies; HIV-1; Humans; Integrase Inhibitors; Male; Middle Aged; Protease Inhibitors; Stavudine; Vitamin B 12; Zalcitabine; Zidovudine | 2002 |
Acute onset lactic acidosis and pancreatitis in the third trimester of pregnancy in HIV-1 positive women taking antiretroviral medication.
Topics: Acidosis, Lactic; Acquired Immunodeficiency Syndrome; Acute Disease; Adult; Anti-HIV Agents; Diagnosis, Differential; Didanosine; Fatal Outcome; Female; Humans; Infant, Newborn; Pancreatitis; Pregnancy; Pregnancy Complications; Pregnancy Complications, Infectious; Pregnancy Trimester, Third; Risk Factors; Stavudine | 2002 |
HIV-1 reverse transcriptase mutations found in a drug-experienced patient confer reduced susceptibility to multiple nucleoside reverse transcriptase inhibitors.
Topics: Acquired Immunodeficiency Syndrome; Amino Acid Sequence; Anti-HIV Agents; Drug Resistance, Multiple, Viral; Genotype; HIV Reverse Transcriptase; Humans; Molecular Sequence Data; Mutation; Reverse Transcriptase Inhibitors; Stavudine | 2001 |
Selection of zidovudine resistance mutations and escape of human immunodeficiency virus type 1 from antiretroviral pressure in stavudine-treated pediatric patients.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Child; Child, Preschool; Drug Resistance, Viral; HIV Reverse Transcriptase; HIV-1; Humans; Infant; Mutagenesis, Site-Directed; Mutation; RNA, Viral; Stavudine; Viral Load; Zidovudine | 2002 |
Stavudine.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Dideoxynucleosides; Humans; Stavudine | 1992 |
Enzymatic and chemical stability of 2',3'-dideoxy-2',3'-didehydropyrimidine nucleosides: potential anti-acquired immunodeficiency syndrome agents.
Topics: Acquired Immunodeficiency Syndrome; Animals; Antiviral Agents; Chemical Phenomena; Chemistry; Cytarabine; Dideoxynucleosides; Drug Stability; Humans; Mice; Stavudine; Zalcitabine | 1989 |
Analytical method for the quantification of 2',3'-didehydro-3'-deoxythymidine, a new anti-human immunodeficiency virus (HIV) agent, by high-performance liquid chromatography (HPLC) and ultraviolet (UV) detection in rat and monkey plasma.
Topics: Acquired Immunodeficiency Syndrome; Animals; Antiviral Agents; Chromatography, High Pressure Liquid; Dideoxynucleosides; Macaca fascicularis; Rats; Species Specificity; Spectrophotometry, Ultraviolet; Stavudine | 1989 |